Showing results (291-300 of 403) with videos related to
Sort By:
Pageof 41
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Circulating factors and insulin resistance. II. The action of the novel myo-inositol cyclic 1,2-inositol phosphate phosphoglycan insulin antagonist from human plasma in regulating pyruvate dehydrogenase phosphataseG T Galasko, S Abe, K Lilley, et al.Stroke|March 6, 1999
Spatz-Lindenberg disease: a rare cause of vascular dementiaA J Larner, D Kidd, P Elkington, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1996
No change in insulin mediators in human skeletal muscle during isometric contraction or recoveryA Katz, E Hultman, L Huang, et al.Biochemical and Biophysical Research Communications|March 20, 1999
A model phosphatase 2C --> phosphatase 1 activation cascade via dual control of inhibitor-1 (INH-1) and DARPP-32 dephosphorylation by two inositol glycan putative insulin mediators from beef liverL C Huang, D Heimark, J Linko, et al.International Journal of Clinical Practice|November 9, 2000
Systemic Weber-Christian disease complicated by partial transverse myelopathyA J Larner, B Marshall, R C Ma, et al.The Journal of Biological Chemistry|April 5, 1992
[3H]ryanodine as a probe of changes in the functional state of the Ca(2+)-release channel in malignant hyperthermiaM J Hawkes, T E Nelson, S L HamiltonNew Horizons (Baltimore, Md.)|February 1, 1996
Carnosine: a novel peptide regulator of intracellular calcium and contractility in cardiac muscleG P Zaloga, P R Roberts, T E NelsonJournal of Neuroscience Research|August 15, 2009
Somatic Ca2+ signaling in cerebellar Purkinje neuronsD L Gruol, J G Netzeband, T E NelsonAnesthesia and Analgesia|June 1, 1983
Spectrum of susceptibility to malignant hyperthermia--diagnostic dilemmaT E Nelson, E H Flewellen, D F GloynaInternational Journal of Sport Nutrition|September 8, 1999
Creatine supplementation and swimming performanceN M Leenders, D R Lamb, T E NelsonPageof 41